SE0302129D0 - Farmaceutiska kompositioner med antibiotisk aktivitet - Google Patents

Farmaceutiska kompositioner med antibiotisk aktivitet

Info

Publication number
SE0302129D0
SE0302129D0 SE0302129A SE0302129A SE0302129D0 SE 0302129 D0 SE0302129 D0 SE 0302129D0 SE 0302129 A SE0302129 A SE 0302129A SE 0302129 A SE0302129 A SE 0302129A SE 0302129 D0 SE0302129 D0 SE 0302129D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
antibiotic activity
antibiotic
aminoacids
stabilizer
Prior art date
Application number
SE0302129A
Other languages
English (en)
Other versions
SE527466C2 (sv
SE0302129L (sv
Inventor
Luca Rampoldi
Luca Pirrone
Sarah Faccin
Alessandro Grassano
Giovanni Gurrieri
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27638551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0302129(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of SE0302129D0 publication Critical patent/SE0302129D0/sv
Publication of SE0302129L publication Critical patent/SE0302129L/sv
Publication of SE527466C2 publication Critical patent/SE527466C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SE0302129A 2002-08-01 2003-07-25 Stabilisering av fosfomycin trometamol SE527466C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001725A ITMI20021725A1 (it) 2002-08-01 2002-08-01 Composizioni farmaceutiche ad attivita' antibiotica.

Publications (3)

Publication Number Publication Date
SE0302129D0 true SE0302129D0 (sv) 2003-07-25
SE0302129L SE0302129L (sv) 2004-02-02
SE527466C2 SE527466C2 (sv) 2006-03-14

Family

ID=27638551

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302129A SE527466C2 (sv) 2002-08-01 2003-07-25 Stabilisering av fosfomycin trometamol

Country Status (29)

Country Link
US (1) US7303755B2 (sv)
JP (1) JP4395338B2 (sv)
KR (1) KR100966977B1 (sv)
AT (1) AT500521B1 (sv)
BE (1) BE1017903A3 (sv)
BR (1) BRPI0302496C1 (sv)
CA (1) CA2434927C (sv)
CH (1) CH696718A5 (sv)
CO (1) CO5480297A1 (sv)
CZ (1) CZ305023B6 (sv)
DE (1) DE10334820B4 (sv)
DK (1) DK178348B1 (sv)
ES (1) ES2224869B1 (sv)
FI (1) FI120080B (sv)
FR (1) FR2852845B1 (sv)
GR (1) GR20030100300A (sv)
HR (1) HRP20030618B1 (sv)
HU (1) HU230575B1 (sv)
IL (1) IL156615A (sv)
IT (1) ITMI20021725A1 (sv)
NL (1) NL1023790C2 (sv)
PL (1) PL209644B1 (sv)
PT (1) PT102995B (sv)
RU (1) RU2333000C2 (sv)
SE (1) SE527466C2 (sv)
SI (1) SI21259B (sv)
SK (1) SK287201B6 (sv)
TR (1) TR200301248A2 (sv)
ZA (1) ZA200305040B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE740685C (de) * 1941-04-11 1943-10-26 Voigt & Haeffner Ag Viertakt-Regelschalter fuer Parallel-, Einzel- und Reihenschaltung von Heizwiderstaenden
ES2244333B1 (es) * 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
PT2482812T (pt) 2009-10-02 2023-01-24 Boehringer Ingelheim Int Composições farmacêuticas compreendendo bi-1356 e metformina
EA021876B1 (ru) * 2010-09-20 2015-09-30 ЛИМОНОВ, Виктор Львович Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ ее получения
ES2385158B1 (es) * 2010-12-24 2013-05-28 Arafarma Group, S.A. Composición farmacéutica de fosfomicina
CN102579466A (zh) * 2011-01-10 2012-07-18 王乐 一种磷霉素或磷霉素精氨酸盐与精氨酸的组合物
US8604078B2 (en) * 2011-04-06 2013-12-10 Carlos Picornell Darder Fosfomycin pharmaceutical composition
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
ITTO20130839A1 (it) * 2013-10-16 2015-04-17 C & G Farmaceutici S R L Composizione a base di fosfomicina trometamolo
DE102014218913A1 (de) 2014-09-19 2016-03-24 Heraeus Medical Gmbh Verfahren zur Herstellung eines antibiotischen Polymehtylmethacrylat-Knochenzementpulvers und ein antibiotisches Polymethtylmethacrylat-Knochenzementpulver
CN104546689B (zh) * 2015-01-07 2019-01-25 同方药业集团有限公司 一种含有甲硝唑的药物组合物
WO2017111718A1 (en) 2015-12-25 2017-06-29 Yusuf Toktamiş Öğün The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
CA3147662A1 (en) 2021-02-10 2022-08-10 Labiana Health, S.L. New fosfomycin tablet formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852434A (en) 1970-09-11 1974-12-03 Merck & Co Inc Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
IT1161974B (it) 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
IT1112282B (it) 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1124610B (it) 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
JPS59104326A (ja) 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
CH660305A5 (de) 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
WO1990003173A1 (en) * 1988-09-26 1990-04-05 Teijin Limited Stable aqueous preparation of active vitamin d¿3?
IT1231013B (it) * 1989-07-27 1991-11-08 Zambon Spa Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'.
US5191094A (en) 1989-07-27 1993-03-02 Zambon Group S.P.A. Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2R,cis)-1,2-epoxypropyl-phosphonate with improved characteristics of stability and processing
IT1244543B (it) 1991-02-01 1994-07-15 La Fa Re Srl Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali
FR2690340B1 (fr) 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
JPH09183730A (ja) * 1995-05-10 1997-07-15 Meiji Seika Kaisha Ltd ホスホマイシン鏡像異性体を含んでなる医薬
DE19712565A1 (de) 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
UA82824C2 (uk) * 2000-06-21 2008-05-26 К'Юбіст Фармасьютікалз, Інк. Композиція і спосіб поліпшення перорального всмоктування протимікробних засобів
WO2002032459A2 (en) * 2000-10-17 2002-04-25 Massachusetts Institute Of Technology Method of increasing the efficacy of antibiotics by complexing with cyclodextrins
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
RU2003124299A (ru) 2005-01-20
ES2224869B1 (es) 2007-07-01
BRPI0302496C1 (pt) 2021-05-25
HRP20030618B1 (en) 2011-10-31
US20040022866A1 (en) 2004-02-05
FI120080B (sv) 2009-06-30
SE527466C2 (sv) 2006-03-14
NL1023790A1 (nl) 2004-02-03
FR2852845A1 (fr) 2004-10-01
SK9762003A3 (en) 2004-02-03
BRPI0302496B1 (pt) 2015-07-28
SK287201B6 (sk) 2010-03-08
BR0302496A (pt) 2004-08-24
JP4395338B2 (ja) 2010-01-06
CA2434927A1 (en) 2004-02-01
CH696718A5 (it) 2007-10-31
CO5480297A1 (es) 2005-01-28
CZ305023B6 (cs) 2015-04-01
SE0302129L (sv) 2004-02-02
PT102995B (pt) 2004-07-30
GR20030100300A (el) 2004-04-22
FI20031078A0 (sv) 2003-07-16
TR200301248A2 (tr) 2004-02-23
BE1017903A3 (fr) 2009-11-03
KR100966977B1 (ko) 2010-06-30
DK178348B1 (da) 2016-01-04
CZ20032096A3 (cs) 2004-03-17
AT500521A1 (de) 2006-01-15
ZA200305040B (en) 2004-05-11
CA2434927C (en) 2011-10-18
SI21259B (sl) 2012-12-31
HU230575B1 (hu) 2017-02-28
FI20031078A (sv) 2004-02-02
IL156615A (en) 2008-11-26
PL209644B1 (pl) 2011-09-30
PT102995A (pt) 2004-02-27
DE10334820A1 (de) 2004-03-11
RU2333000C2 (ru) 2008-09-10
ITMI20021725A1 (it) 2002-10-31
US7303755B2 (en) 2007-12-04
BRPI0302496B8 (pt) 2016-09-13
JP2004067682A (ja) 2004-03-04
KR20040012569A (ko) 2004-02-11
DK200301097A (da) 2004-02-02
ES2224869A1 (es) 2005-03-01
DE10334820B4 (de) 2020-02-06
HU0302441D0 (en) 2003-09-29
AT500521B1 (de) 2007-11-15
FR2852845B1 (fr) 2006-01-06
PL361518A1 (en) 2004-02-09
NL1023790C2 (nl) 2004-03-10
HRP20030618A2 (en) 2004-04-30
HUP0302441A2 (hu) 2005-07-28
SI21259A (sl) 2004-02-29
IL156615A0 (en) 2004-01-04

Similar Documents

Publication Publication Date Title
HK1079519A1 (en) Furyl compounds
RS93604A (en) Substituted phenylacetamides and their use as glucokinase activators
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
NO20044995L (no) Heterosykliske forbindelser
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
ATE396993T1 (de) Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität
HK1079522A1 (en) Thienyl compounds
SE0302129D0 (sv) Farmaceutiska kompositioner med antibiotisk aktivitet
MXPA06000407A (es) Isomero c cci-779.
HK1088890A1 (en) Biguanide and dihydrotriazine derivatives
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
SE9903290D0 (sv) Novel compounds
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
ATE373636T1 (de) Amidderivate als inhibitoren der enzymatischen aktivität von renin
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
TW200509794A (en) Novel anthelmintic and insecticidal compositions
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
ATE491709T1 (de) Pyrrolidinohydrochinazoline
NO20050781L (no) Cefalosporiner
DE60216920D1 (en) Tryptase-inhibitoren

Legal Events

Date Code Title Description
NUG Patent has lapsed